By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OphthaliX Inc. 

123 West Nye Lane
Suite 129
Carson City  Nevada  89706  U.S.A.
Phone: 972-3-9241114 Fax: 972-3-9249378


Company News
OphthaliX Inc. Announces Phase II Glaucoma Data 7/5/2016 6:17:20 AM
OphthaliX Inc. Announces CF101 Is Granted Patent In Japan For Intraocular Pressure A Key Cause Of Glaucoma 12/17/2015 7:22:56 AM
Can-Fite BioPharma (CFBI) Subsidiary OphthaliX Inc. Signs Definitive Agreement To Acquire Improved Vision Systems 6/19/2015 6:14:03 AM
OphthaliX Inc. Signs Term Sheet To Acquire Improved Vision Systems Ltd. 5/4/2015 7:28:36 AM
OphthaliX Inc. Provides An Update On Its Clinical Developments And Strategic Plans 6/9/2014 10:26:20 AM
OphthaliX Inc.'s Dry Eye Drug CF101 Fails To Meet Goals In Phase 3 Study 12/30/2013 6:39:35 AM
OphthaliX Inc. Release: European Patent Office Grants a Patent for the Treatment of Sjogren's Syndrome 9/4/2013 9:10:17 AM
OphthaliX Inc. Appoints Dr. Michael Belkin to its Board of Directors 7/3/2013 6:40:07 AM
OphthaliX Inc. Release: Third Party Presented New Data at the ARVO 2013 Annual Meeting in Seattle, WA, Validating the use of A3 Adenosine Receptor Agonists for Lowering Intra Ocular Pressure and for the Treatment of Glaucoma 5/13/2013 6:32:51 AM
OphthaliX Inc. Announces the Completion of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study 3/18/2013 9:41:26 AM